Carnegie acted as joint lead manager and joint book-runner in the initial public offering of Recipharm on NASDAQ OMX Stockholm. Recipharm provides contract manufacturing and development services for other pharmaceutical companies. Manufacturing primarily involves production of pharmaceuticals in various forms.April 2014.
Healthcare
Initial public offering of Recipharm (SE) on NASDAQ OMX Stockholm — SEK 1.5 billion
April 2014